trending Market Intelligence /marketintelligence/en/news-insights/trending/s4kir4drfgsjmwgtaef9aq2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

USPTO gives Advanced Proteome notice of allowance for cancer treatment proteins

State Of Singapore Online Video Subscription

Power Forecast Briefing: Capacity Shortfalls to Test the Renewable Energy Transition

Episode 43 - More Change, M&A On Horizon For Equity Research Industry

Cable Nets Struggle With Little Revenue Growth Expanding Programming Budgets


USPTO gives Advanced Proteome notice of allowance for cancer treatment proteins

Advanced Proteome Therapeutics Corp. received a notice of allowance from the U.S. Patent and Trademark Office for its patent application involving linkage among two or more proteins for potential cancer treatment.

The proteins involved in the patent application are designed to increase potency and duration of action against tumor cells. Certain members of the compounds included in the patent have also slowed tumor growth in animal models.

The application also includes claims to protect the company's invention concerning specific proteins linked to other proteins and show activity against tumor cells.